BlackRock
TIL icon

BlackRock’s Instil Bio TIL Stock Holding History

BlackRock’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$427K Buy
55,504
+3,486
+7% +$28.1K ﹤0.01% 4618
2026
Q1 		$429K Buy
52,018
+805
+2% +$6.53K ﹤0.01% 4566
2025
Q4 		$563K Sell
51,213
-10,469
-17% -$155K ﹤0.01% 4451
2025
Q3 		$1.1M Buy
61,682
+10,949
+22% +$278K ﹤0.01% 4265
2025
Q2 		$1.06M Sell
50,733
-7,238
-12% -$151K ﹤0.01% 4232
2025
Q1 		$1.01M Sell
57,971
-1,796
-3% -$37.3K ﹤0.01% 4184
2024
Q4 		$1.14M Buy
59,767
+6,973
+13% +$213K ﹤0.01% 4195
2024
Q3 		$3.55M Sell
52,794
-8,225
-13% -$194K ﹤0.01% 3833
2024
Q2 		$628K Hold
61,019
– – ﹤0.01% 4285
2024
Q1 		$659K Buy
61,019
+23,419
+62% +$257K ﹤0.01% 4307
2023
Q4 		$287K Sell
37,600
-30,282
-45% -$219K ﹤0.01% 4552
2023
Q3 		$581K Buy
67,882
+4,274
+7% +$43.1K ﹤0.01% 4386
2023
Q2 		$701K Sell
63,608
-164,876
-72% -$2.02M ﹤0.01% 4388
2023
Q1 		$3.02M Sell
228,484
-8,570
-4% -$127K ﹤0.01% 3863
2022
Q4 		$2.99M Buy
237,054
+5,817
+3% +$287K ﹤0.01% 3952
2022
Q3 		$22.4M Buy
231,237
+21,235
+10% +$2.43M ﹤0.01% 2973
2022
Q2 		$19.4M Buy
210,002
+41,952
+25% +$5.94M ﹤0.01% 3107
2022
Q1 		$36.1M Buy
168,050
+1,953
+1% +$456K ﹤0.01% 2777
2021
Q4 		$56.8M Buy
166,097
+122,298
+279% +$47.2M ﹤0.01% 2571
2021
Q3 		$15.7M Buy
43,799
+2,032
+5% +$759K ﹤0.01% 3439
2021
Q2 		$16.1M Buy
41,767
+40,267
+2,684% +$14.9M ﹤0.01% 3425
2021
Q1 		$752K Buy
+1,500
New +$770K ﹤0.01% 4552

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

BlackRock's TIL Position: Q2 2026 in Review

BlackRock increased its Instil Bio (TIL) stake by 6.7% in Q2 2026, buying an estimated $28.1K and bringing the position to 55,504 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #4618.

BlackRock first reported a position in TIL in Q1 2021 and has held it in 22 quarters since. The position peaked at $56.8M in Q4 2021. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • BlackRock held 55,504 shares of Instil Bio worth $427K as of Q2 2026.
  • BlackRock bought 3,486 Instil Bio shares in Q2 2026, an estimated $28.1K.
  • Instil Bio made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4618 holding.
  • BlackRock first reported a position in Instil Bio in Q1 2021 and has held it in 22 quarters since.
  • BlackRock's Instil Bio position peaked at $56.8M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.